References
Feuillan P., Jones J.V., Barnes K., Oerter-Klein K., Cutler G.B. Jr. Reproductive axis following discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long-term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. J. Clin. Endocrinol. Metab. 1999, 84: 44–49.
Feuillan P.P., Jones J.V., Barnes K.M., Oerter-Klein K., Cutler G.B. Jr. Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing analog therapy. J. Clin. Endocrinol. Metab. 2000, 85: 4036–4038.
Manasco P.K., Pescovitz O.H., Hill S.C., Cutler G.B. Jr. Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRHdependent precocious puberty. J. Pediatr. 1989, 115: 105–108.
Manasco P.K., Pescovitz, I.H., Feuillan P.P., Hench K.D., Barnes K.M., Jones J., Hill S.C., Loriaux D.L., Cutler G.B. Jr. Resumption of puberty after long-term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty. J. Clin. Endocrinol. Metab. 1988, 67: 368–372.
Heger S., Partsch C.-J., Sippell W.G. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density and reproductive function. J. Clin. Endocrinol. Metab. 1999, 84: 4583–4590.
Lazar L., Kauli R., Bruchis C., Nordenberg J., Galatzer A., Pertzelan A. Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response. Eur. J. Endocrinol. 1995, 133: 403–406.
Zaatreh M., Tennison M., Greenwood R.S. Successful treatment of hypothalamic seizures and precocious puberty with GnRH analog. Neurology 2000, 55: 1908–1910.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feuillan, P.P., Jones, J.V., Barnes, K. et al. Follow-up of children and young adults after GnRH-agonist therapy for central precocious puberty. J Endocrinol Invest 24, 734–736 (2001). https://doi.org/10.1007/BF03343918
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343918